Roche Pays $220 Million For Blood Testing Innovator

Law360, New York (July 2, 2013, 4:40 PM EDT) -- Swiss pharmaceutical titan Roche Holding AG announced Tuesday that it will shell out $220 million to acquire Constitution Medical Investors Inc., which is developing a new testing system for blood diseases.

Roche said that more payments could follow if certain incentives are met, but did not provide any details. It made the purchase in an effort to bolster its competitive position in the laboratory hematology testing business.

“With this acquisition, we will further strengthen our commitment to hematology and drive toward integrated laboratory solutions with innovative products...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.